-
Charles River Discusses Business Outlook (CRL)
Tuesday, December 14, 2010 - 8:57am | 196Charles River Laboratories International, Inc. (NYSE: CRL) shared today its outlook for its business, highlighting its unique portfolio in the industry, which is well aligned with clients' increasing demand for integrated offerings from discovery through preclinical development. The Company also...
-
Jefferies Raises PT On TMO
Tuesday, December 14, 2010 - 8:54am | 22Jefferies has raised the price target on Thermo Fisher Scientific (NYSE: TMO) from $63 to $64.
-
Compugen Announces Positive Therapeutic Effect of CGEN-15001 (CGEN)
Tuesday, December 14, 2010 - 8:44am | 620Compugen Ltd. (NASDAQ: CGEN) announced today that administration of CGEN-15001 in an animal model of rheumatoid arthritis (RA) dramatically ameliorates the clinical symptoms of the disease. These results, combined with earlier results in an animal model of multiple sclerosis (MS), strongly support...
-
MDU RESOURCES (MDU) - Profit Tracks
Tuesday, December 14, 2010 - 8:33am | 597Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid....
-
Top 4 Stocks In The Medical Laboratories & Research Industry With The Highest Cash (PPDI, ALR, CVD, DGX)
Tuesday, December 14, 2010 - 6:28am | 137Below are the top medical laboratories & research stocks on the NYSE and the NASDAQ in terms of cash. Pharmaceutical Product Development Inc (NASDAQ: PPDI) had $530.43 million in total cash and no debt for the latest quarter. Alere Inc (NYSE: ALR) had $493.27 million in total cash for the...
-
MDU RESOURCES (MDU) - Profit Tracks
Tuesday, December 14, 2010 - 1:00am | 597Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid....
-
Thermo Fisher to Acquire Dionex - Analyst Blog
Monday, December 13, 2010 - 4:33pm | 596Thermo Fisher (TMO) has decided to acquire California based Dionex Corporation (DNEX), a leading manufacturer and marketer of chromatography systems for $118.50 per share or total consideration of $2.1 billion. The offer price is at 21% premium over the closing price of Dionex as on December 10...
-
Nektar Therapeutics Falls 8.3% (NKTR)
Monday, December 13, 2010 - 4:15pm | 131Shares of Nektar Therapeutics (Nasdaq: NKTR) are currently down 8.3% at $12.90 per share during Monday afternoon trading. Today's trading range for shares of Nektar Therapeutics has been between $12.74 and $13.45 per share. The consensus price target of analysts covering the company's stock is $16....
-
Thermo Fisher to Acquire Dionex - Analyst Blog
Monday, December 13, 2010 - 4:05pm | 596Thermo Fisher (TMO) has decided to acquire California based Dionex Corporation (DNEX), a leading manufacturer and marketer of chromatography systems for $118.50 per share or total consideration of $2.1 billion. The offer price is at 21% premium over the closing price of Dionex as on December 10...
-
Dionex Hits 52-Week High On Acquisition News (DNEX)
Monday, December 13, 2010 - 3:23pm | 140News that Scientific instrument maker Thermo Fisher Scientific Inc (NYSE: TMO) will buy Dionex Corporation (Nasdaq: DNEX) for $118.50 per share has sent the share prices of both companies higher. While shares of Thermo Fisher Scientific Inc are up just 3.8% at $55.06, shares of Dionex Corporation...
-
Options Brief: Sequenom, Inc. (SQNM)
Monday, December 13, 2010 - 11:59am | 101Shares of Sequenom, Inc. (NASDAQ: SQNM) are higher on the session by 1.70%, trading at $6.58. Overall call volume is now running at 2.05x the daily average, with 19% of all calls traded being purchases on the offer. 2,064 contracts have traded on the session so far. Sequenom, Inc. is a diagnostic...
-
Options Brief: Thermo Fisher Scientific (TMO)
Monday, December 13, 2010 - 11:53am | 80Shares of Thermo Fisher Scientific (NYSE: TMO) are higher on the session by 4.24%, trading at $55.29. Overall call volume is now running at 5.68x the daily average, with 65% of all calls traded being purchases on the offer. 1,022 contracts have traded on the session so far. Thermo Fisher...
-
Benzinga's Volume Movers (DNEX, LULU, MIPS, PSMT)
Monday, December 13, 2010 - 11:48am | 175Dionex Corporation (NASDAQ: DNEX) shares moved up 20.30% to $118.10 at 10:46 am. The volume of DNEX shares traded was 2404% higher than normal. Thermo Fisher Scientific Inc (NYSE: TMO) announced its plans to buy DNEX for $2.1 billion, or $118.50 per share in cash, representing a 20.7% premium over...
-
Morning Market Movers (FONR, DNEX, TEAR, NSTC)
Monday, December 13, 2010 - 11:14am | 160Fonar Corporation (NASDAQ: FONR) shares surged 43.44% to $1.75 at 10:10 am. FONR UPRIGHT MRI customer won a jury decision for an anti-trust lawsuit against CareCore National LLC. Dionex Corporation (NASDAQ: DNEX) jumped 20.20% to $118.00. Thermo Fisher Scientific Inc (NYSE: TMO) announced its plans...
-
News Summary (TMO, DNEX, WMT, DELL, CML)
Monday, December 13, 2010 - 10:42am | 224Thermo Fisher Scientific Inc (NYSE: TMO) announced its plans to buy Dionex Corp (NASDAQ: DNEX) for $2.1 billion, or $118.50 per share in cash, representing a 20.7% premium over DNEX's closing price on Friday. The deal is likely to close in the first quarter of 2011. DNEX shares surged about 20%...